Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nicole Lavender"'
Publikováno v:
AIMS Medical Science, Vol 2, Iss 4, Pp 271-294 (2015)
Background: Oxidative stress and detoxification mechanisms have been commonly studied in Prostate Cancer (PCa) due to their function in the detoxification of potentially damaging reactive oxygen species (ROS) and carcinogens. However, findings have b
Externí odkaz:
https://doaj.org/article/e06115f5dd0242348143a2bbead58172
Autor:
Ann Richmond, Mark Boothby, Harold L. Moses, Ingrid A. Mayer, Melinda Sanders, Mark C. Kelley, Gregory D. Ayers, Colt McClain, Andrew C. Johnson, Nicole Lavender, Tammy Sobolik, Jinming Yang, Anna E. Vilgelm, Oriana E. Hawkins, Sergey V. Novitskiy, Philip Owens, Jiqing Sai
This file describes additional methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131e542ea51fe21cdf507397fb0097d3
https://doi.org/10.1158/1078-0432.22462245
https://doi.org/10.1158/1078-0432.22462245
Autor:
Ann Richmond, Mark Boothby, Harold L. Moses, Ingrid A. Mayer, Melinda Sanders, Mark C. Kelley, Gregory D. Ayers, Colt McClain, Andrew C. Johnson, Nicole Lavender, Tammy Sobolik, Jinming Yang, Anna E. Vilgelm, Oriana E. Hawkins, Sergey V. Novitskiy, Philip Owens, Jiqing Sai
Supplementary Figure 1: BKM120 inhibited CD4+ T cell, not CD8+ T cell proliferation and had small effects on PyMT specific T cell mediated cytotoxicity only at a 1:50 E/T cell ratio. Supplementary Figure 2: Tumors were initiated as described in Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1023a7d3ea5e15ff49781e8c208d2a27
https://doi.org/10.1158/1078-0432.22462248.v1
https://doi.org/10.1158/1078-0432.22462248.v1
Autor:
Ann Richmond, Mark Boothby, Harold L. Moses, Ingrid A. Mayer, Melinda Sanders, Mark C. Kelley, Gregory D. Ayers, Colt McClain, Andrew C. Johnson, Nicole Lavender, Tammy Sobolik, Jinming Yang, Anna E. Vilgelm, Oriana E. Hawkins, Sergey V. Novitskiy, Philip Owens, Jiqing Sai
Purpose: Metastatic breast cancers continue to elude current therapeutic strategies, including those utilizing PI3K inhibitors. Given the prominent role of PI3Kα,β in tumor growth and PI3Kγ,δ in immune cell function, we sought to determine whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49cf3e3a268adaab339768ddbc400af
https://doi.org/10.1158/1078-0432.c.6525051
https://doi.org/10.1158/1078-0432.c.6525051
Autor:
Andrew C. Johnson, Colt M. McClain, Oriana E. Hawkins, Jinming Yang, Tammy Sobolik, Melinda E. Sanders, Mark Boothby, Harold L. Moses, Sergey V. Novitskiy, Mark C. Kelley, Anna E. Vilgelm, Nicole Lavender, Ingrid A. Mayer, Ann Richmond, Gregory D. Ayers, Jiqing Sai, Philip Owens
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(13)
Purpose: Metastatic breast cancers continue to elude current therapeutic strategies, including those utilizing PI3K inhibitors. Given the prominent role of PI3Kα,β in tumor growth and PI3Kγ,δ in immune cell function, we sought to determine whethe
Autor:
Ingrid M. Meszoely, Ann Richmond, Vandana G. Abramson, Jinming Yang, Andrew Johnson, Sergey V. Novitskiy, Nicole Lavender, Mark C. Kelley, Ingrid A. Mayer, Linda W. Horton, Jiqing Sai
Publikováno v:
Cancer Research. 76:1410-1410
Background: PI3K inhibitors have shown anti-tumor activity in breast cancer and are currently being investigated in multiple clinical trials. Despite the number of trials studying treatment efficacy, tolerability, and survival, little attention has b
Publikováno v:
Cancer Research. 75:422-422
Background: Although many effective breast cancer treatments exist, metastasis remains a major problem. Increasing evidence suggests that leukocyte-associated chemokines may play an important role in tumor growth and metastasis. For instance, recent
Autor:
Nicole Lavender, Jiqing Sai, Ann Richmond, Philip Owens, Jinming Yang, C. Andrew Johnson, Gregory D. Ayers, Sheau-Chiann Chen
Publikováno v:
BMC Cancer
Background The role of the chemokine CCL2 in breast cancer is controversial. While CCL2 recruits and activates pro-tumor macrophages, it is also reported to enhance neutrophil-mediated anti-tumor activity. Moreover, loss of CCL2 in early development